查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941771

美國持續正壓呼吸器（CPAP）市場規模、銷售、平均售價趨勢、佔有率和預測分析報告：按性別、最終用途和細分市場預測（2026-2033 年）

U.S. Continuous Positive Airway Pressure Devices Market Size, Unit Volume, Average Selling Price Trends, Share & Forecast Analysis Report, By Connectivity, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國持續正壓呼吸器市場概述

據估計，2025 年美國持續正壓呼吸器(CPAP) 市值為 13.5 億美元，預計到 2033 年將達到 20.7 億美元。

預計從 2026 年到 2033 年，該行業將以 5.50% 的複合年成長率成長，這主要得益於睡眠呼吸中止症和呼吸系統疾病的患病率上升、持續正壓呼吸器的技術進步、人們對睡眠呼吸中止症的認知和診斷不斷提高，以及有利的報銷政策。

例如，聯邦醫療保險（Medicare）為被診斷患有阻塞型睡眠呼吸中止症的患者提供三個月的持續性正壓呼吸器（CPAP）設備及其配件試用期。由於肥胖、久坐的生活方式和人口老化等因素，睡眠呼吸中止症和其他呼吸系統疾病在美國的發病率正在上升。根據美國疾病管制與預防中心（CDC）2024年5月發布的估計數據，2021年8月至2023年8月期間，美國成年人的肥胖率將達到40.3%，男女之間沒有顯著差異。 41至60歲成年人的肥胖率高於20至39歲以及60歲以上的人。肥胖率的上升顯著加劇了睡眠呼吸中止症的盛行率，進而推動了對CPAP設備的需求。

此外，CPAP技術的不斷創新顯著提高了患者的舒適度和治療效果。現代CPAP呼吸機配備了更安靜的馬達、更緊湊的設計、整合式加濕系統和先進的數據追蹤功能。這些改進解決了患者常見的噪音和不適感等問題，從而提高了治療依從性。

政府衛生機構和非營利組織經常進行宣傳活動，向公眾普及睡眠呼吸中止症及其治療的必要性。例如，2024年5月，美國疾病管制與預防中心（CDC）將睡眠呼吸中止症納入了一項更廣泛的公共衛生宣傳活動，該活動旨在改善睡眠衛生並促進慢性病管理。

在美國，租賃模式在推廣持續正壓呼吸器的使用方面發揮關鍵作用，同時也影響CPAP設備的定價和收入結構。 CPAP設備通常以「先租後買」的方式提供給患者，租期為10-13個月，具體期限取決於保險報銷政策，主要包括聯邦醫療保險（Medicare）和私人保險公司的報銷政策。這種模式透過降低患者的前期成本、提高治療啟動率以及使保險公司能夠在患者完全擁有設備之前核實其治療依從性，從而有助於提高市場滲透率。

然而，這種方法會延遲製造商即時確認設備銷售收入，將購買力轉移到醫療設備供應商，並增加長期病患依從性、遠端監控和更換週期（面罩、導管、過濾器等）的重要性。 CPAP 租賃正在促進美國持續陽壓呼吸器(CPAP) 設備產業的穩定持續需求、提高價格敏感性，並更加重視連網設備和基於服務的差異化。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場趨勢與展望
  • 市場動態
  • 美國CPAP設備市場分析工具：PESTEL分析法
    • 政治/法律法規
    • 經濟與社會
    • 科技
    • 環境
  • 美國CPAP市場分析工具：波特五力分析

第4章：美國CPAP設備市場：連結性估算與趨勢分析

  • 美國CPAP設備市場：連結性差異分析
  • 2025 年和 2033 年連結性變化分析與市佔率分析
  • 美國連結市場估算與預測（按連結類型分類）
  • 連接類型
    • 藍牙連接的CPAP
    • 支援Wi-Fi和蜂窩網路連接的CPAP呼吸機
    • 混合連接
  • 未連接

第5章 美國CPAP設備市場：依最終用途分類的估算與趨勢分析

  • 美國CPAP設備市場：最終用途差異分析
  • 按最終用途分類的變化分析和市場佔有率分析（2025 年和 2033 年）
  • 美國CPAP設備市場：按最終用途分類的估算和預測
  • 居家醫療環境
  • 醫院和診所
  • 其他（長期照護機構等）

第6章 競爭情勢

  • 公司分類
  • Strategies of Market Players for Entry and Exit and Their Impact on Market Competitors
  • 企業市場分析
  • Company Share Analysis, from 2012 to 2025（%）
  • 公司簡介/上市資訊
    • ResMed
    • Koninklijke Philips NV
    • Fisher &Paykel Healthcare Limited
    • React Health（3B Medical）
    • Lowenstein Medical
    • BMC Medical
    • Wellell（Apex Medical）
    • Armstrong Medical
    • Breas Medical
    • SEFAM
    • Transcend Inc.（Somnetics International, Inc.）
    • Trudell Medical（Vyaire）
    • Medical Depot, Inc. dba Drive DeVilbiss Healthcare
    • Invacare Corporation
    • Apria Healthcare Group LLC
    • Rotech Healthcare Inc.
    • Others
  • US CPAP Devices：Sales Model Composition（Rental vs. Direct Purchase）, 2020-2024
  • US PAP Device DME Distributor-Level Profiles
    • 林卡控股有限公司
    • Rotec Healthcare Co., Ltd.
    • AdapHealth
    • Aeroflow Health
    • CPAPeople.com
    • AHOM
    • CPAP商店
    • Sleep Direct
    • 埃奇帕克醫療用品
    • Apria Healthcare
Product Code: GVR-4-68040-556-8

U.S. Continuous Positive Airway Pressure Devices Market Summary

The U.S. continuous positive airway pressure devices market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.07 billion by 2033, growing at a CAGR of 5.50% from 2026 to 2033. This is attributed to the rising prevalence of sleep apnea and respiratory disorders, technological advancements in continuous positive airway pressure devices (CPAP) devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies.

For instance, Medicare covers a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea. The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.

Moreover, continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, thereby increasing therapy adherence rates.

Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, the CDC in the U.S. incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.

The rental model plays a significant role in shaping the adoption of continuous positive airway pressure devices in the U.S., as well as pricing and revenue dynamics. CPAP devices are commonly provided to patients on a rent-to-own basis, typically over a 10 to 13-month period, driven largely by insurance reimbursement policies, including those of Medicare and private payers. In addition, this model reduces upfront costs for patients, enhances therapy initiation rates, and enables payers to verify compliance before full ownership, thereby facilitating broader market penetration.

However, it also slows immediate device sales revenue recognition for manufacturers, shifts purchasing power toward DME providers, and increases the importance of long-term patient adherence, remote monitoring, and replacement cycles (such as masks, tubing, and filters). CPAP rentals contribute to steady, recurring demand, greater price sensitivity, and stronger emphasis on connected devices and service-based differentiation in the U.S. continuous positive airway pressure (CPAP) devices industry.

U.S. Continuous Positive Airway Pressure Devices Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2026 to 2033. For this study, Grand View Research has segmented the U.S. continuous positive airway pressure devices market report based on connectivity and end use.

  • Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Connected
    • Bluetooth-Connected CPAP
    • Wi-Fi & Cellular Connected CPAP
    • Hybrid-Connected
  • Non-Connected
  • End Use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Home Care Settings
  • Hospitals & Clinics
  • Others (Long-Term Care Facilities, etc.)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. CPAP Devices Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Connectivity segment outlook
      • 2.1.2.2. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recalls & failure
      • 3.3.2.2. Complex regulatory framework pertaining to CPAP devices
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Growing adoption of CPAP devices in home care settings
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Regulatory and reimbursement challenges
  • 3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
    • 3.4.1. Political & Legal
    • 3.4.2. Economic & Social
    • 3.4.3. Technology
    • 3.4.4. Environment
  • 3.5. U.S. CPAP Market Analysis Tools: Porter's

Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis

  • 4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
  • 4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
  • 4.3. Connectivity Movement & Market Share Analysis, 2025 & 2033
  • 4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
  • 4.5. Connected
    • 4.5.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
    • 4.5.2. Bluetooth-Connected CPAP
      • 4.5.2.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
    • 4.5.3. Wi-Fi & Cellular Connected CPAP
      • 4.5.3.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
    • 4.5.4. Hybrid-Connected
      • 4.5.4.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
  • 4.6. Non-Connected
    • 4.6.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)

Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. CPAP Devices Market: End Use Movement Analysis
  • 5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
  • 5.3. End Use Movement & Market Share Analysis, 2025 & 2033
  • 5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
  • 5.5. Home Care Settings
    • 5.5.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
  • 5.6. Hospitals & Clinics
    • 5.6.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
  • 5.7. Others (Long-Term Care Facilities, etc.)
    • 5.7.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategies of Market Players for Entry and Exit and Their Impact on Market Competitors
  • 6.3. Company Market Position Analysis
  • 6.4. Company Share Analysis, from 2012 to 2025 (%)
  • 6.5. Company Profiles/Listing
    • 6.5.1. ResMed
      • 6.5.1.1. Overview
      • 6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Koninklijke Philips N.V.
      • 6.5.2.1. Overview
      • 6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Fisher & Paykel Healthcare Limited
      • 6.5.3.1. Overview
      • 6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. React Health (3B Medical)
      • 6.5.4.1. Overview
      • 6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Lowenstein Medical
      • 6.5.5.1. Overview
      • 6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. BMC Medical
      • 6.5.6.1. Overview
      • 6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Wellell (Apex Medical)
      • 6.5.7.1. Overview
      • 6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Armstrong Medical
      • 6.5.8.1. Overview
      • 6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Breas Medical
      • 6.5.9.1. Overview
      • 6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. SEFAM
      • 6.5.10.1. Overview
      • 6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Transcend Inc. (Somnetics International, Inc.)
      • 6.5.11.1. Overview
      • 6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Trudell Medical (Vyaire)
      • 6.5.12.1. Overview
      • 6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Medical Depot, Inc. dba Drive DeVilbiss Healthcare
      • 6.5.13.1. Overview
      • 6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Invacare Corporation
      • 6.5.14.1. Overview
      • 6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Apria Healthcare Group LLC
      • 6.5.15.1. Overview
      • 6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Rotech Healthcare Inc.
      • 6.5.16.1. Overview
      • 6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Others
      • 6.5.17.1. Overview
      • 6.5.17.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives
  • 6.6. U.S CPAP Devices: Sales Model Composition (Rental vs. Direct Purchase), 2020 - 2024
  • 6.7. U.S. PAP Device DME Distributor-Level Profiles
    • 6.7.1. Lincare Holdings Inc.
      • 6.7.1.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.1.2. % contribution of each manufacturer within that DME
      • 6.7.1.3. Sales model mix (% rental vs. direct)
      • 6.7.1.4. Key partnerships and manufacturer
      • 6.7.1.5. Notable strategic changes post-Philips recall
    • 6.7.2. Rotech Healthcare Inc.
      • 6.7.2.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.2.2. % contribution of each manufacturer within that DME
      • 6.7.2.3. Sales model mix (% rental vs. direct)
      • 6.7.2.4. Key partnerships and manufacturer
      • 6.7.2.5. Notable strategic changes post-Philips recall
    • 6.7.3. AdaptHealth
      • 6.7.3.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.3.2. % contribution of each manufacturer within that DME
      • 6.7.3.3. Sales model mix (% rental vs. direct)
      • 6.7.3.4. Key partnerships and manufacturer
      • 6.7.3.5. Notable strategic changes post-Philips recall
    • 6.7.4. Aeroflow Health
      • 6.7.4.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.4.2. % contribution of each manufacturer within that DME
      • 6.7.4.3. Sales model mix (% rental vs. direct)
      • 6.7.4.4. Key partnerships and manufacturer
      • 6.7.4.5. Notable strategic changes post-Philips recall
    • 6.7.5. CPAP.com
      • 6.7.5.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.5.2. % contribution of each manufacturer within that DME
      • 6.7.5.3. Sales model mix (% rental vs. direct)
      • 6.7.5.4. Key partnerships and manufacturer
      • 6.7.5.5. Notable strategic changes post-Philips recall
    • 6.7.6. AHOM
      • 6.7.6.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.6.2. % contribution of each manufacturer within that DME
      • 6.7.6.3. Sales model mix (% rental vs. direct)
      • 6.7.6.4. Key partnerships and manufacturer
      • 6.7.6.5. Notable strategic changes post-Philips recall
    • 6.7.7. The CPAP Shop
      • 6.7.7.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.7.2. % contribution of each manufacturer within that DME
      • 6.7.7.3. Sales model mix (% rental vs. direct)
      • 6.7.7.4. Key partnerships and manufacturer
      • 6.7.7.5. Notable strategic changes post-Philips recall
    • 6.7.8. Sleep Direct
      • 6.7.8.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.8.2. % contribution of each manufacturer within that DME
      • 6.7.8.3. Sales model mix (% rental vs. direct)
      • 6.7.8.4. Key partnerships and manufacturer
      • 6.7.8.5. Notable strategic changes post-Philips recall
    • 6.7.9. Edgepark Medical Supplies
      • 6.7.9.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.9.2. % contribution of each manufacturer within that DME
      • 6.7.9.3. Sales model mix (% rental vs. direct)
      • 6.7.9.4. Key partnerships and manufacturer
      • 6.7.9.5. Notable strategic changes post-Philips recall
    • 6.7.10. Apria Healthcare
      • 6.7.10.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.10.2. % contribution of each manufacturer within that DME
      • 6.7.10.3. Sales model mix (% rental vs. direct)
      • 6.7.10.4. Key partnerships and manufacturer
      • 6.7.10.5. Notable strategic changes post-Philips recall

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. continuous positive airway pressure devices market revenue estimates and forecast, by connectivity, 2021 - 2033 (USD Million) (000' Units)
  • Table 4 U.S. continuous positive airway pressure devices market revenue estimates and forecast, by end use, 2021 - 2033 (USD Million) (000' Units)

List of Figures

  • Fig. 1 U.S. CPAP Devices Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for Market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Technology segment outlook
  • Fig. 11 Application segment outlook
  • Fig. 12 End Use segment outlook
  • Fig. 13 Competitive landscape
  • Fig. 14 U.S. CPAP Devices Market: Market dynamics
  • Fig. 15 U.S. CPAP Devices Market: Porter's analysis
  • Fig. 16 U.S. CPAP Devices Market: PESTLE analysis
  • Fig. 17 U.S. CPAP Devices Market: Connectivity segment dashboard
  • Fig. 18 U.S. CPAP Devices Market: Connectivity movement share analysis
  • Fig. 19 Connected Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 20 Bluetooth-Connected CPAP Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 21 Wi-Fi & Cellular Connected CPAP Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 22 Hybrid-Connected Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 23 Non-Connected Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 24 U.S. CPAP Devices Market: End Use Segment Dashboard
  • Fig. 25 U.S. CPAP Market: End Use Movement Share Analysis
  • Fig. 26 Home Care Settings Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 27 Hospitals & Clinics Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 28 Others (Long-Term Care Facilities, etc) Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 29 Company categorization
  • Fig. 30 Company Market Share Analysis (2012 - 2025) Metrics Covered: Unit Volume, Average Selling Price (ASP), Market Value
  • Fig. 31 Strategic framework